TCL Archive Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines. March 31, 2000
TCL Archive Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion May 31, 2002
TCL Archive Managed Care Plans Seek Cost Efficacy, Not Research, Center Directors Warned March 17, 1995
TCL Archive DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year February 27, 1987
